Preliminary experience using a polyetheretherketone (PEEK) cage in the treatment of cervical disc disease

CMUR > China Medical University Hospital > Jurnal articles > Item 310903500/29791

Please use this identifier to cite or link to this item: http://ir.cmu.edu.tw/ir/handle/310903500/29791

Title:	Preliminary experience using a polyetheretherketone (PEEK) cage in the treatment of cervical disc disease
Authors:	Cho, DY;Liau, WR;Lee, WY;Liu, JT;Chiu, CL;Sheu, PC
Contributors:	附設醫院神經外科;China Med Coll Hosp, Dept Neurosurg, Taichung, Taiwan
Date:	2002
Issue Date:	2010-09-24 14:42:41 (UTC+8)
Publisher:	LIPPINCOTT WILLIAMS & WILKINS
Abstract:	Strains of extended-spectrum P-lactamase-producing Klebsiella pneumoniae (ESBL-KP) have emerged worldwide. Concomitant ciprofloxacin resistance with ESBL production in K. pneumoniae isolates would severely restrict treatment options. Among 39 (18.5%) of 211 ESBL-KP isolates resistant to ciprofloxacin (MIC, greater than or equal to4 mug/ ml), 37 (95%) were high level resistant (MIC, greater than or equal to16 mug/ml). These isolates were also cross resistant to the newer fluoroquinolones, including levofloxacin, gatifloxacin, gemifloxacin, and garenoxacin (BMS 284756). Sitafloxacin was most active against these ciprofloxacin-resistant ESBL-KP isolates with MICs for 67% of the isolates being less than or equal to2 mug/ml. The molecular epidemiology of these multiresistant isolates was investigated by automated ribotyping and pulsed-field gel electrophoresis (PFGE). Ribotyping identified 18 different strains among the 39 ciprofloxacin-resistant ESBL-KP isolates. The majority (67%) of these isolates were contained in six ribo-groups which were further confirmed by PFGE. The distribution of the six major strains of ciprofloxacin-resistant ESBL-KP within Taiwan included one (ribogroup 255.3-PFGE type E) with a nationwide distribution and several institution-specific strains. Interhospital cooperation appears necessary, with strict infection control practices coupled with restriction of fluoroquinolone and extended-spectrum P-lactam use to control both the major epidemic strain and the more diverse strains observed within individual institutions.
Relation:	NEUROSURGERY 51(6):1343-1349
Appears in Collections:	[China Medical University Hospital] Jurnal articles

Files in This Item:

There are no files associated with this item.

Loading...